I have mentioned, previously, how I was puzzled that drug studies at Yale, for OCD sufferers, are combined with CBT. I didn’t see how an accurate trial could be conducted when people might be responding to therapy at the same time. The reply I received, from a psychiatrist in charge, was that the study was not compromised because CBT is not a variable, i.e. everyone on the study receives it. I replied that any therapy is, by definition, a variable, because people respond so differently. I was, understandably, ignored!
A few years later, I was informed by a psychologist at the Maudsley, that I would be unable to begin inpatient therapy at the Bethlem unit, if I had recently started new medication. The reason for this made perfect sense, although the unit is a treatment and not a research centre, response to therapy is carefully monitored and an element of research is being conducted at the same time. A new medication would cloud the picture.
Yesterday, I was reading Lee Baer’s ‘Imp of the Mind’. He was discussing a priest who was about to begin a drug study. The priest asked for advice over therapy and Lee Baer explained he couldn’t help him at that time. He wrote in his book:
“The difficulty for me, I told him, was that because of the rules of the study, I was not allowed to give anyone instructions about using behaviour therapy for their symptoms (since behaviour therapy is a highly effective treatment for obsessions and compulsions and could invalidate the results of the drug trial).”
Yale is a prestigious university, it has such eminent psychiatrists working there. How can they be making this glaring error?!
- Hot topic